A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Clinical trial NCT00211276 · COMPLETED

Trial details

NCT number: NCT00211276
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell

Start date: 2005-03-01
Primary completion: 2007-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.